The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin
Abstract
BACKGROUND: Women with polycystic ovary syndrome (PCOS) have an increased prevalence of insulin resistance (IR) and related disorders. Elevated serum levels of cellular adhesion molecules (CAMs) reflect low-grade chronic inflammation and have been associated with several insulin-resistant states. The objective of this study is to investigate whether soluble inflammatory markers [soluble intercellular adhesion molecule-1 (sICAM-1), soluble endothelial leukocyte adhesion molecule-1 (sE-selectin), soluble vascular cell adhesion molecule-1 (sVCAM-1) and C-reactive protein (CRP)] are altered in PCOS and to further elucidate the effect of metformin treatment on their levels. METHODS: Two young populations were studied [62 women with PCOS and 45 normal women of similar age, BMI and waist-to-hip ratio (WHR)]. Plasma levels of sICAM-1, sVCAM-1, sE-selectin and high-sensitivity CRP (hsCRP) were measured in both groups. Additionally, the effect of metformin on these molecules was investigated in 22 women with PCOS who accepted to metformin protocol (1700 mg daily for a 6-month period). RESULTS: In the total population studied, plasma levels of hsCRP (mg/l), sICAM-1 (ng/ml) and sE-selectin (ng/ml) were higher in the PCOS group compared with those in controls (hsCRP 1.31 +/- 0.22 versus 0.92 +/- 0.27, P = 0.014, sICAM-1 301.21 +/- 24.80 versus 209.86 +/- 17.05, P = 0.025, sE-selectin 57.37 +/- 4.08 versus 45.67 +/- 4.62, P = 0.045, respectively). sVCAM-1 (ng/ml) did not differ statistically among the two groups (P = 0.896). A significant reduction in hsCRP and sVCAM-1 was achieved after 6 months of metformin administration: PCOS pretreatment hsCRP 1.92 +/- 0.60 versus PCOS post-treatment hsCRP 0.52 +/- 0.26, P = 0.005; PCOS pretreatment sVCAM-1 668.09 +/- 98.38 versus PCOS post-treatment sVCAM-1 365.82 +/- 99.77, P = 0.039. CONCLUSION: These findings imply the presence of chronic inflammation in women with PCOS. Metformin decreases the levels of plasma inflammatory indices. Further investigation is required to determine whether these findings may prove to be of clinical significance for PCOS patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Inflammation, Atherosclerosis, and Coronary Artery Disease
Hansson, G. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043430 · Cited by 8,773
Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850
Katz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., & Quon, M. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6661 · Cited by 3,931 · cited 1×
“QUICKI is defined as: QUICKI = 1/[log ( fasting insulin) + log (fasting glucose)] (Katz et al., 2000 ).”
Danesh, J., Wheeler, J. G., Hirschfield, G. M., Eda, S., Eiriksdottir, G., Rumley, A., Lowe, G. D. O., Pepys, M. B., & Gudnason, V. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032804 · Cited by 2,953
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis*
Dunaif, A. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.6.0318 · Cited by 2,458
Ridker, P. M., Buring, J. E., Cook, N. R., & Rifai, N. (2003) · Circulation · doi:10.1161/01.cir.0000055014.62083.05 · Cited by 2,292
Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.
Ehrmann, D. A., Barnes, R. B., Rosenfield, R. L., Cavaghan, M. K., & Imperial, J. (1999) · Diabetes Care · doi:10.2337/diacare.22.1.141 · Cited by 1,257 · cited 8×
“…the most common endocrinopathy of reproductive age (Diamanti-Kandarakis et al., 1999), which is characterized by anovulation, hyperandrogenaemia and, frequently, insulin resistance (IR) represents a disorder with increased risk for type 2 diabetes (T2D) (Ehrmann et al., 1999; Orio et al., 2004).”
InfluentialA major role for VCAM-1, but not ICAM-1, in early atherosclerosis
Cybulsky, M. I., Iiyama, K., Li, H., Zhu, S., Chen, M., Iiyama, M., Davis, V., Gutierrez-Ramos, J.-C., Connelly, P. W., & Milstone, D. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11871 · Cited by 1,217
Inflammatory Markers and the Risk of Coronary Heart Disease in Men and Women
Pai, J. K., Pischon, T., Ma, J., Manson, J. E., Hankinson, S. E., Joshipura, K., Curhan, G. C., Rifai, N., Cannuscio, C. C., Stampfer, M. J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040967 · Cited by 1,174
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis
Dunaif, A. (1997) · Endocrine Reviews · doi:10.1210/er.18.6.774 · Cited by 1,155
Diamanti‐Kandarakis, E., Kouli, C., Bergiele, A. T., Filandra, F. A., Tsianateli, T. C., Spina, G., Zapanti, E. D., & Bartzis, M. I. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.11.4006 · Cited by 1,110
Self-citationVelazquez, E. M., Mendoza, S., Hamer, T., Sosa, F., & Glueck, C. J. (1994) · Metabolism · doi:10.1016/0026-0495(94)90209-7 · Cited by 865
Adams, J., Polson, D. W., Abdulwahid, N., Morris, D. V., Franks, S., Mason, H. D., Tucker, M., Price, J., & Jacobs, H. S. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92552-8 · Cited by 798
Clustering of metabolic factors and coronary heart disease
Wilson, P. W. F., Kannel, W. B., Silbershatz, H., & D'Agostino, R. B. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.10.1104 · Cited by 712
Biomarkers of Endothelial Dysfunction and Risk of Type 2 Diabetes Mellitus
Meigs, J. B. (2004) · JAMA · doi:10.1001/jama.291.16.1978 · Cited by 643
Low grade chronic inflammation in women with polycystic ovarian syndrome
Kelly, C. C. J., Lyall, H., Petrie, J. R., Gould, G. W., Connell, J. M. C., & Sattar, N. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.6.7580 · Cited by 640
Improved Endothelial Function With Metformin in Type 2 Diabetes Mellitus
Mather, K. J., Verma, S., & Anderson, T. J. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01129-9 · Cited by 513
Coronary Heart Disease Risk Factors in Women With Polycystic Ovary Syndrome
Talbott, E., Guzick, D., Clerici, A., Berga, S., Detre, K., Weimer, K., & Kuller, L. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.7.821 · Cited by 504
Polycystic Ovary Syndrome Is Associated With Endothelial Dysfunction
Paradisi, G., Steinberg, H. O., Hempfling, A., Cronin, J., Hook, G., Shepard, M. K., & Baron, A. D. (2001) · Circulation · doi:10.1161/01.cir.103.10.1410 · Cited by 475
Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus
Ovalle, F., & Azziz, R. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(02)03111-4 · Cited by 428
Endothelial Dysfunction in Obesity and Insulin Resistance: A Road to Diabetes and Heart Disease
Caballero, A. E. (2003) · Obesity Research · doi:10.1038/oby.2003.174 · Cited by 416
Prevalence and Predictors of Coronary Artery Calcification in Women with Polycystic Ovary Syndrome
Christian, R. C., Dumesic, D. A., Behrenbeck, T., Oberg, A. L., Sheedy, P. F., & Fitzpatrick, L. A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030334 · Cited by 400
Inflammation and Coronary Artery Disease
Alexander, R. W. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408183310709 · Cited by 400
Nestler, J. E., & Jakubowicz, D. J. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.12.4431 · Cited by 368
Nagi, D. K., & Yudkin, J. S. (1993) · Diabetes Care · doi:10.2337/diacare.16.4.621 · Cited by 353
Do Lee, C. (2001) · American Journal of Epidemiology · doi:10.1093/aje/154.8.758 · Cited by 345
Boulman, N., Levy, Y., Leiba, R., Shachar, S., Linn, R., Zinder, O., & Blumenfeld, Z. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031096 · Cited by 330
Diamanti-Kandarakis, E., Kouli, C., Tsianateli, T., & Bergiele, A. (1998) · European Journal of Endocrinology · doi:10.1530/eje.0.1380269 · Cited by 323
Self-citationPolycystic ovary syndrome: Syndrome XX?
Sam, S., & Dunaif, A. (2003) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2003.08.002 · Cited by 302
Tarkun, İ., Arslan, B. Ç., Cantürk, Z., Türemen, E., Şahı̇n, T., & Duman, C. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0751 · Cited by 296
Morin-Papunen, L. C., Koivunen, R. M., Ruokonen, A., & Martikainen, H. K. (1998) · Fertility and Sterility · doi:10.1016/s0015-0282(98)00011-9 · Cited by 290
Orio, F., Palomba, S., Spinelli, L., Cascella, T., Tauchmanovà, L., Zullo, F., Lombardi, G., & Colao, A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032049 · Cited by 275
Leinonen, E., Hurt-Camejo, E., Wiklund, O., Hultén, L. M., Hiukka, A., & Taskinen, M.-R. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(02)00371-4 · Cited by 274
Orio, F., Palomba, S., Cascella, T., Di Biase, S., Manguso, F., Tauchmanovà, L., Nardo, L. G., Labella, D., Savastano, S., Russo, T., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0628 · Cited by 256
VCAM-1 is critical in atherosclerosis
Ley, K., & Huo, Y. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13005 · Cited by 246
Metformin Reduces Serum C-Reactive Protein Levels in Women with Polycystic Ovary Syndrome
Morin-Papunen, L., Rautio, K., Ruokonen, A., Hedberg, P., Puukka, M., & Tapanainen, J. S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021688 · Cited by 245
Diamanti-Kandarakis, E., Spina, G., Kouli, C., & Migdalis, I. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.10.7904 · Cited by 229
Self-citationEscobar-Morreale, H. F., Botella-Carretero, J. I., Villuendas, G., Sancho, J., & San Millán, J. L. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031365 · Cited by 198
Chu, N. V., Kong, A. P. S., Kim, D. D., Armstrong, D., Baxi, S., Deutsch, R., Caulfield, M., Mudaliar, S. R., Reitz, R., Henry, R. R., et al. (2002) · Diabetes Care · doi:10.2337/diacare.25.3.542 · Cited by 196
Evolving Concepts in the Triad of Atherosclerosis, Inflammation and Thrombosis
Corti, R., Hutter, R., Badimón, J. J., & Fuster, V. (2004) · Journal of Thrombosis and Thrombolysis · doi:10.1023/b:thro.0000036027.39353.70 · Cited by 187
Soluble E-selectin in cardiovascular disease and its risk factors: A review of the literature
Roldán, V., Marín, F., Lip, G., & Blann, A. (2003) · Thrombosis and Haemostasis · doi:10.1160/th02-09-0083 · Cited by 182
The polycystic ovary syndrome per se is not associated with increased chronic inflammation
Mohlig, M., Spranger, J., Osterhoff, M., Ristow, M., Pfeiffer, A., Schill, T., Schlosser, H., Brabant, G., & Schofl, C. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1500525 · Cited by 182
Increased levels of serum advanced glycation end‐products in women with polycystic ovary syndrome
Diamanti‐Kandarakis, E., Piperi, C., Kalofoutis, A., & Creatsas, G. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02170.x · Cited by 178
Self-citationMetformin administration improves endothelial function in women with polycystic ovary syndrome
Diamanti-Kandarakis, E., Alexandraki, K., Protogerou, A., Piperi, C., Papamichael, C., Aessopos, A., Lekakis, J., & Mavrikakis, M. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01910 · Cited by 178
Self-citationGrant, P. J. (1996) · Diabetes Care · doi:10.2337/diacare.19.1.64 · Cited by 173
Beneficial effects of metformin on haemostasis and vascular function in man
Grant, P. J. (2003) · Diabetes & Metabolism · doi:10.1016/s1262-3636(03)72787-6 · Cited by 167
Caballero, A. E., Delgado, A., Aguilar-Salinas, C. A., Herrera, A. N., Castillo, J. L., Cabrera, T., Gomez-Perez, F. J., & Rull, J. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0019 · Cited by 151 · cited 2×
“However, the differential effect of metformin on plasma concentrations of sICAM-1 and sE-selectin cannot be explained in this study; it is possible that longer duration of treatment is required, as it has been shown in PCOS and other IR populations (Morin-Papunen et al., 1998; UKPDS, 1998; Caballero, 2003; Grant, 2003…”
Blüher, M., UNGER, R. H., Rassoul, F., Richter, V., & Paschke, R. (2002) · Diabetologia · doi:10.1007/s00125-001-0723-3 · Cited by 151
TNF- and Hyperandrogenism: A Clinical, Biochemical, and Molecular Genetic Study
Escobar-Morreale, H. F., Calvo, R. M., Sancho, J., & Millán, J. L. S. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.8.7770 · Cited by 121
Villuendas, G., Millán, J. L. S., Sancho, J., & Escobar-Morreale, H. F. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8309 · Cited by 119
Cardiovascular risk in women with polycystic ovarian syndrome (PCOS)
Bickerton, A. S. T., Clark, N. M., Meeking, D. R., Shaw, K. M., Crook, M. A., Lumb, P. J., Turner, C., & Cummings, M. H. (2005) · Journal of Clinical Pathology · doi:10.1136/jcp.2003.015271 · Cited by 119
Talbott, E. O., Zborowski, J. V., Boudreaux, M. Y., McHugh-Pemu, K. P., Sutton-Tyrrell, K., & Guzick, D. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032110 · Cited by 108
Peral, B., Millán, J. L. S., Castello, R., Moghetti, P., & Escobar-Morreale, H. F. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.8.8715 · Cited by 99
Association of Polymorphisms in the Interleukin 6 Receptor Complex with Obesity and Hyperandrogenism
Escobar-Morreale, H. F., Calvo, R. M., Villuendas, G., Sancho, J., & Millán, J. L. S. (2003) · Obesity Research · doi:10.1038/oby.2003.136 · Cited by 97
Antiatherogenic properties of metformin: the experimental evidence
Mamputu, J., Wiernsperger, N. F., & Renier, G. (2003) · Diabetes & Metabolism · doi:10.1016/s1262-3636(03)72790-6 · Cited by 84
Diamanti‐Kandarakis, E., Palioniko, G., Alexandraki, K., Bergiele, A. T., Koutsouba, T., & Bartzis, M. I. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1500793 · Cited by 84
Self-citationKado, S., & Nagata, N. (1999) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(99)00083-2 · Cited by 82
Alterations in cardiac flow parameters in patients with polycystic ovarian syndrome
Tıraş, M. B., Yalcin, R., Noyan, V., Maral, İ., Yıldırım, M., Dörtlemez, Ö., & Daya, S. K. (1999) · Human Reproduction · doi:10.1093/humrep/14.8.1949 · Cited by 74
Cardiovascular Risk in Women With Polycystic Ovarian Syndrome
Guzick, D. S. (1996) · Seminars in Reproductive Medicine · doi:10.1055/s-2007-1016308 · Cited by 60
Relation Between Soluble Adhesion Molecules and Insulin Sensitivity in Type 2 Diabetic Individuals
Targher, G., Bonadonna, R. C., Alberiche, M., Zenere, M. B., Muggeo, M., & Bonora, E. (2001) · Diabetes Care · doi:10.2337/diacare.24.11.1961 · Cited by 54
Kowalska, I., Strączkowski, M., Szelachowska, M., Kinalska, I., Prokop, J., Bachórzewska-Gajewska, H., & St[ecedil]pien, A. (2002) · Metabolism · doi:10.1053/meta.2002.32802 · Cited by 49
Bahçeci, M., Tuzcu, A., Canoruç, N., Tüzün, Y., Kıdır, V., & Aslan, Ç. (2004) · Hormone Research in Paediatrics · doi:10.1159/000081973 · Cited by 41
Hammadeh, M. E., Fischer‐Hammadeh, C., Hoffmeister, H., Huebner, U., Georg, T., Rosenbaum, P., & Schmidt, W. K. (2003) · American Journal of Reproductive Immunology · doi:10.1034/j.1600-0897.2003.00056.x · Cited by 33
Nasiek, M., Kos‐Kudła, B., Ostrowska, Z., Marek, B., Kajdaniuk, D., Siemińśka, L., & Fołtyn, W. (2004) · Gynecological Endocrinology · doi:10.1080/09513590400014313 · Cited by 14
Cited by
Norman, R. J., Dewailly, D., Legro, R. S., & Hickey, T. E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61345-2 · Cited by 1,360
Chronic Low Grade Inflammation in Pathogenesis of PCOS
Rudnicka, E., Suchta, K., Grymowicz, M., Calik-Ksepka, A., Smolarczyk, K., Duszewska, A. M., Smolarczyk, R., & Meczekalski, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073789 · Cited by 680
Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis
Escobar-Morreale, H. F., Luque-Ramírez, M., & González, F. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.11.036 · Cited by 517
Ovulation: Parallels With Inflammatory Processes
Duffy, D. M., Ko, C., Jo, M., Brannstrom, M., & Curry, T. E. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00075 · Cited by 513
Palomba, S., Falbo, A., Zullo, F., & Orio, F. (2009) · Endocrine Reviews · doi:10.1210/er.2008-0030 · Cited by 426
Metadata
- Authors
- Diamanti-Kandarakis, E., Paterakis, T., Alexandraki, K., Piperi, C., Aessopos, A., Katsikis, I., Katsilambros, N., Kreatsas, G., & Panidis, D.
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-02-23
- Volume
- 21
- Issue
- 6
- Pages
- 1426-1431
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W2148804426
- Cited by
- 258
- References
- 66
- FWCI
- 20.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.